Clinical trials: Hydroxychloroquine Adverse Reaction
Covid19, Hydroxychloroquine Adverse Reaction
Development and Validation of "Ready-to-Use" Inhalable Forms of Hydroxychloroquine for Treatment of COVID-19
In this project, we aimed at developing new "Ready-to-Use" inhalable forms of HCQ that can be used directly through nebulization or using dry powder inhalers (DPIs).
- Trial name
- NCT04477083
- Testing
- inhalable hydroxychloroquine (HCQ), supportive and symptomatic treatment
- Where
- Egypt
- Volunteers
- 40 people
- Sponsor
- Mansoura University
Coronavirus Infection, Hydroxychloroquine Adverse Reaction
Safety And Efficacy Of Hydroxychloroquine For At Risk Population (SHARP) Against COVID-19
The Coronavirus Disease 2019 (COVID-19) pandemic has placed tremendous stress on the global economy since its outbreak in December 2019.
- Trial name
- SHARP COVID-19 (NCT04342156)
- Testing
- Hydroxychloroquine Sulfate 200 milligram (mg) Tab
- Volunteers
- healthy volunteers welcome
- Sponsor
- Tan Tock Seng Hospital